Picture of Knotus Co logo

278650 Knotus Co Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Momentum

Relative Strength (%)
1m-20.44%
3m+8.77%
6m+147.27%
1yr+171.1%
Volume Change (%)
10d/3m-78.6%
Price vs... (%)
52w High-84.1%
50d MA-34.02%
200d MA+29.11%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)5.19
PEG Ratio (f)0.06
EPS Growth (f)947.66%
Dividend Yield (f)2.15%
Valuation (ttm)IndustryMarket
Price to Book Value7.03
Price to Tang. Book7.24
Price to Free Cashflown/a
Price to Sales7.25
EV to EBITDA33.04

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital8.49%
Return on Equity13.98%
Operating Margin16.94%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueKR₩m29,339.6537,237.4446,039.6458,519.8364,403.0376,600124,10041.99%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+66.24-6.6+6.44+62.16-11.2+33.43+1389.01n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Knotus Co EPS forecast chart

Profile Summary

KNOTUS Co.,Ltd. is a Korea-based company principally engaged in the nonclinical experiment business. Along with subsidiaries, the Company operates its business through three segments. The Nonclinical Contract Research Organization (CRO) Business segment conducts nonclinical experiments on new developed substances such as new drugs, and tests the efficacy and pharmacodynamics of the substances. This segment also provides services including new drug development related equipment, software and analysis of experimental results. The Animal Laboratory Construction Business segment is engaged in the construction and design of animal laboratories and the supply of reagent consumables. The Pet Business segment is engaged in the development of animal medicines and the sale of pet supplies.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    March 31st, 2022
    Incorporated
    April 19th, 2012
    Public Since
    November 27th, 2019
    No. of Shareholders
    8,584
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    70,255,377

    278650 Share Price Performance

    Upcoming Events for 278650

    Similar to 278650

    Picture of ABion logo

    ABion

    kr flag iconKorea Exchange - KOSDAQ

    Picture of ABL Bio logo

    ABL Bio

    kr flag iconKorea Exchange - KOSDAQ

    Picture of ADM Korea logo

    ADM Korea

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Amicogen logo

    Amicogen

    kr flag iconKorea Exchange - KOSDAQ

    Picture of AprilBio Co logo

    AprilBio Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ

    Or unlock with your email

    Or unlock with your email